JG
DYN icon

Jain Global’s Dyne Therapeutics DYN Stock Holding History

Jain Global’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.58M Buy
+116,341
New +$2.16M 0.01% 712
2026
Q1 		– Sell
-162,047
Closed -$3.17M – 1318
2025
Q4 		$3.17M Sell
162,047
-482,035
-75% -$9.13M 0.02% 505
2025
Q3 		$8.15M Buy
644,082
+47,915
+8% +$546K 0.04% 270
2025
Q2 		$5.68M Buy
+596,167
New +$6.56M 0.04% 312

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jain Global's DYN Position: Q2 2026 in Review

Jain Global opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 116,341 shares worth $2.58M. The stake represents 0.01% of the portfolio and ranks #712 among its holdings. This is a return to the name: Jain Global previously reported a position in DYN as recently as Q4 2025.

Jain Global first reported a position in DYN in Q2 2025 and has held it in 4 quarters since. The position peaked at $8.15M in Q3 2025. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Jain Global held 116,341 shares of Dyne Therapeutics worth $2.58M as of Q2 2026.
  • Dyne Therapeutics was a new Jain Global position in Q2 2026.
  • Dyne Therapeutics made up 0.01% of Jain Global's portfolio in Q2 2026, its #712 holding.
  • Jain Global first reported a position in Dyne Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Jain Global's Dyne Therapeutics position peaked at $8.15M in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.